Crosstree defines the Drug and Device Outsourcing (“DDO”) Industry as companies generating over 33% of their revenues from the following activities: Discovery, Development, Contract Development and Manufacturing (“CDMO”), Laboratory, Logistics, Sales & Communication, and Technology (hereby defined as “segments”). Crosstree further divides each segment into multiple sub-segments. The table below illustrates this unique taxonomy and the industry, segment, and sub-segment relationship.